Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Under certain conditions in pinnacle 9 9.2 and 9.4 the customer can modify the geometry of a beam or change the parameters for a bolus and the software does not invalidate the control point dose. this occurs in two situations: - the customer sets the 'speed up collimator movements' field in the beam's eye view options window to yes sets the 'store control point dose' field in the control points window to yes computes dose for a beam that uses control points and then uses the collimator tool (shown at left) to adjust the collimator or jaw positions. - the customer sets the 'store control point dose' field in the control points window to yes computes dose on a beam that uses control points and bolus and then changes a parameter for a bolus that is applied to that beam.